Skip to main content

Advertisement

Log in

Prognosis of Fibrosarcoma in Patients With and Without a History of Radiation for Nasopharyngeal Carcinoma

  • Bone and Soft Tissue Sarcomas
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Purpose

To determine whether radiation-induced fibrosarcoma (RIF) in patients with a history of radiotherapy for nasopharyngeal carcinoma (NPC) was associated with an inferior prognosis compared to sporadic fibrosarcoma of the head and neck.

Methods

Forty-two patients with RIF who previously received radiotherapy for NPC and 124 patients with sporadic fibrosarcoma of the head and neck were identified between January 1965 and December 2013 at our institution. Information on clinicopathologic characteristics and treatment was abstracted from medical records. The primary end point was disease-specific survival (DSS).

Results

The median latency from NPC diagnosis to RIF diagnosis was 9.9 years (range 3.1–36.8 years). RIF was diagnosed at an older age than sporadic fibrosarcoma. Treatment modality was significantly different between the two groups, with only 64.3 % of the RIF group receiving surgery ± adjuvant treatment versus 91.1 % in the sporadic fibrosarcoma group (P < 0.001). Patients with RIF had poorer 5-year DSS compared to the sporadic fibrosarcoma group (36.2 vs. 50.4 %; P = 0.026). Multivariate analysis of the combined group indicated that patient group (P = 0.032), tumor, node, metastasis classification system stage (P = 0.019), histologic grade (P = 0.046) and treatment modality (P < 0.001) were independent variables affecting DSS.

Conclusions

Compared to patients with sporadic fibrosarcoma, NPC survivors who develop RIF are older at diagnosis of fibrosarcoma and have an inferior prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet. 2005;365:2041–54.

    Article  PubMed  Google Scholar 

  2. Tham IW, Hee SW, Yeo RM, et al. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy—the national cancer centre Singapore experience. Int J Radiat Oncol Biol Phys. 2009;75:1481–6.

    Article  PubMed  Google Scholar 

  3. Kam MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440–50.

    Article  PubMed  Google Scholar 

  4. Chen MC, Feng IJ, Lu CH, et al. The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979–2003). Ann Oncol. 2008;19:1180–6.

    Article  PubMed  Google Scholar 

  5. Scélo G, Boffetta P, Corbex M, et al. Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries. Cancer Causes Control. 2007;18:269–78.

    Article  PubMed  Google Scholar 

  6. Kong L, Lu JJ, Hu C, Guo X, Wu Y, Zhang Y. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy. Cancer. 2006;107:1287–93.

    Article  PubMed  Google Scholar 

  7. Xi M, Liu MZ, Wang HX, et al. Radiation-induced sarcoma in patients with nasopharyngeal carcinoma: a single-institution study. Cancer. 2010;116:5479–86.

    Article  PubMed  Google Scholar 

  8. Gladdy RA, Qin LX, Moraco N, et al. Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas? J Clin Oncol. 2010;28:2064–9.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Shaheen M, Deheshi BM, Riad S, et al. Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcoma. Clin Orthop Relat Res. 2006;450:76–81.

    Article  PubMed  Google Scholar 

  10. Leclercq C, Penel N, Grosjean J, et al. Prognosis of post-irradiation soft tissue sarcoma: case–control study. Rev Med Interne. 2004;25:866–71.

    Article  CAS  PubMed  Google Scholar 

  11. Inoue YZ, Frassica FJ, Sim FH, Unni KK, Petersen IA, McLeod RA. Clinicopathologic features and treatment of postirradiation sarcoma of bone and soft tissue. J Surg Oncol. 2000;75:42–50.

    Article  CAS  PubMed  Google Scholar 

  12. Bjerkehagen B, Småstuen MC, Hall KS, Skjeldal S, Smeland S, Fosså SD. Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival? Histopathologic type: an independent prognostic factor in primary soft tissue sarcoma of the extremity. Br J Cancer. 2012;106:297–306.

    Article  CAS  PubMed  Google Scholar 

  13. Cahan WG, Woodard HQ, Higinbotham NL, Stewart FW, Coley BL. Sarcoma arising in irradiated bone: report of eleven cases 1948. Cancer. 1998;82:8–34.

    Article  CAS  PubMed  Google Scholar 

  14. Arlen M, Higinbotham NL, Huvos AG, Marcove RC, Miller T, Shah IC. Radiation-induced sarcoma of bone. Cancer. 1971;28:1087–99.

    Article  CAS  PubMed  Google Scholar 

  15. Billings SD, McKenney JK, Folpe AL, Hardacre MC, Weiss SW. Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. Am J Surg Pathol. 2004;28:781–8.

    Article  PubMed  Google Scholar 

  16. Katz SC, Baldwin K, Karakousis G, et al. Soft tissue sarcoma diagnosed subsequent to lymphoma is associated with prior radiotherapy and decreased survival. Cancer. 2011;117:4756–63.

    Article  PubMed  Google Scholar 

  17. Richards WG, Godleski JJ, Yeap BY, et al. Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases. Cancer. 2010;116:1510–7.

    Article  PubMed  Google Scholar 

  18. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999;117:54–63.

    Article  CAS  PubMed  Google Scholar 

  19. Lagrange JL, Ramaioli A, Chateau MC, et al. Sarcoma after radiation therapy: retrospective multiinstitutional study of 80 histologically confirmed cases. Radiation Therapist and Pathologist Groups of the Federation Nationale des Centres de Lutte Contre le Cancer. Radiology. 2000;216:197–205.

    Article  CAS  PubMed  Google Scholar 

  20. Singer S, Demetri GD, Baldini EH, Fletcher CD. Management of soft tissue sarcomas: an overview and update. Lancet Oncol. 2000;1:75–85.

    Article  CAS  PubMed  Google Scholar 

  21. Cha C, Antonescu CR, Quan ML, Maru S, Brennan MF. Long-term results with resection of radiation-induced soft tissue sarcomas. Ann Surg. 2004;239:903–9.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Thijssens KM, van Ginkel RJ, Suurmeijer AJ, et al. Radiation-induced sarcoma: a challenge for the surgeon. Ann Surg Oncol. 2005;12:237–45.

    Article  PubMed  Google Scholar 

  23. Bjerkehagen B, Smeland S, Walberg L, et al. Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital. Acta Oncol. 2008;47:1475–82.

    Article  CAS  PubMed  Google Scholar 

  24. Yeang MS, Tay K, Ong WS, et al. Outcomes and prognostic factors of post-irradiation and de novo sarcomas of the head and neck: a histologically matched case–control study. Ann Surg Oncol. 2013;20:3066–75.

    Article  PubMed  Google Scholar 

  25. Franco Gutierrez V, Llorente Pendas JL, Coca Pelaz A, et al. Radiation-induced sarcomas of the head and neck. J Craniofac Surg. 2008;19:1287–91.

    Article  PubMed  Google Scholar 

  26. Brockstein B. Management of sarcomas of the head and neck. Curr Oncol Rep. 2004;6:321–7.

    Article  PubMed  Google Scholar 

  27. O’Neill JP, Bilsky MH, Kraus D. Head and neck sarcomas: epidemiology, pathology, and management. Neurosurg Clin N Am. 2013;24:67–78.

    Article  PubMed  Google Scholar 

  28. Riad S, Biau D, Holt GE, et al. The clinical and functional outcome for patients with radiation-induced soft tissue sarcoma. Cancer. 2012;118:2682–92.

    Article  PubMed  Google Scholar 

  29. De Bruin ML, Burgers JA, Baas P, et al. Malignant mesothelioma after radiation treatment for Hodgkin’s lymphoma. Blood. 2009;113:3679–81.

    Article  PubMed  Google Scholar 

  30. Elkin EB, Klem ML, Gonzales AM, et al. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin’s lymphoma: a multi-institutional, matched cohort study. J Clin Oncol. 2011;29:2466–73.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgment

Supported in part by grants from the Sci-Tech Project Foundation of Guangdong Province (2012B061700083) and the National Natural Science Foundation of China (81201748).

Disclosure

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mian Xi MD.

Additional information

Peng Zhang and Lei Zhao contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 18 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, P., Zhao, L., Zhu, YJ. et al. Prognosis of Fibrosarcoma in Patients With and Without a History of Radiation for Nasopharyngeal Carcinoma. Ann Surg Oncol 24, 434–440 (2017). https://doi.org/10.1245/s10434-016-5589-1

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-016-5589-1

Keywords

Navigation